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Methods
WPI nanocarriers encapsulating FeSO4 (WPI-NC) were prepared using cold
homogenisation method. The mucoadhesive polysaccharide chitosan (CHI) was
added to the aqueous phase to prepare chitosan coated nanocarriers (WPI-CHI-
NC).
Nanocarrier physiochemical characteristics were assessed by particle size, zeta
potential and morphological analysis. Iron uptake from formulations was
compared by caco-2 cell uptake experiments using simulated GI fluid, with
intracellular ferritin protein as a measure of iron absorption and pure FeSO4 as
reference.
Potential toxic effects of nanocarrier formulations on caco-2 cells were assessed
by carrying out the colourimetric MTT assay incubating caco-2 cell monolayers
with formulations diluted at a final iron concentrations of 20, 50 and 100 µM (and
equivalent volumes of corresponding blank iron-free nanocarriers).
FeSO4 was used as a reference standard for quantitaive iron absorption
experiments. Equivalent amounts of iron (20 µM) from each formulation was
added to caco-2 cells cultured in six-well plates (n = 6 per sample) for 2 hours, the
estimated physiological transit time through the duodenum, and cells harvested
after 24 hours.
Intracellular ferritin concentration was determined by ELISA. Ferritin
concentrations were then standardised against total protein concentration and ng
ferritin/mg protein considered an indice of iron absorption in Caco-2 cells. Data is
presented as mean ± SEM and difference between samples was analysed by
ANOVA followed by Tukey's post-hoc test using the PRISM software package.
Introduction
Iron deficiency is the most prevalent nutritional disorders worldwide (WHO).
Ferrous sulphate (FeSO4) is the most common iron supplement/fortificant,
however, it causes gastrointestinal (GI) side effects and has a poor sensory
profile. Encapsulation approaches are used to overcome this, but poor absorption
is a limitation.
Milk proteins are generally inexpensive, with an established safety and
biocompatibility profile and are widely used in the food industry for their nutritional
and functional properties.
Results
Fig. 2. Particle size and morphological analysis was carried out by scanning electron
microscopy as well as using a Malvern Zetasizer. All formulations were found to be within a
submicron size range (113.76 ± 7 nm – 125.92 ± 12 nm) favourable for intestinal
permeability. SEM analysis was in agreement with Zetasizer measurements, with
nanocarrier particle size observed to be of nanoscale dimensions.
Fig. 3. Caco-2 cell viability as assessed by MTT assay following 48 hour (a) and 72 hour (b)
incubation with nanocarrier formulations containing increasing drug concentrations (n=6).
Results demonstrate that the nanocarrier formulations did not exert any significant toxic
effects upon caco-2 cell viability.
Fig. 4. Quantitative iron uptake from the nanocarrier formulations was compared by carrying
out caco-2 cell uptake experiments with intracellular ferritin protein as a measure of iron
absorption. Caco-2 iron absorption from WPI-NC (88.96 ± 8.9 ng/mg) was only 23% of
FeSO4 control (374.61 ± 22.03 ng/mg). However, chitosan inclusion significantly increased
cellular iron absorption, with WPI-CHI-NC iron absorption (410.1ng/mg ± 24.77) 365.9 %
higher than WPI-NC and 9.6 % higher than FeSO4 control (P ≤ 0.05).
Summary
 Low level iron absorption from WPI-NC composed of WPI alone may potentially be attributed to poor nanocarrier integrity in the GI microenvironment.
 Chitosan inclusion leads to formation of robust hybrid protein-polysaccharide nanocarriers possessing greater membrane permeability resulting in high
cellular iron delivery.
 Our results demonstrate the potential of WPI as a novel biomaterial for formulation of nanocarriers for micronutrient delivery.
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Whey proteins isolate (WPI) is
obtained by processing and
filtration of milk whey (Fig. 1.). It
has a high protein content
(97.5%) and is virtually lactose,
carbohydrate and fat free.
WPI is readily available and
biocompatible, and also has
physiochemical properties such
as self assembly. These
characteristics make it a
promising material for
encapsulation and formulation of
bioactive compounds.
We describe for the first time preparation and characterisation of novel
WPI composite nanocarriers for oral iron formulation and delivery.
Fig. 1. Separation of dairy milk into protein
fractions
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